Amgen Reports First Quarter 2019 Financial Results

Go back to Amgen Reports First Quarter 2019 Financial Results

Amgen (AMGN) Tops Q1 EPS by 8c, Updates FY Guidance

April 30, 2019 4:03 PM EDT

Amgen (NASDAQ: AMGN) reported Q1 EPS of $3.56, $0.08 better than the analyst estimate of $3.48. Revenue for the quarter came in at $5.56 billion versus the consensus estimate of $5.52 billion.

GUIDANCE:

Amgen sees FY2019 EPS of $13.25-$14.30, versus the consensus of $14.10. Amgen sees... More